comparemela.com

Latest Breaking News On - Transgene stock exchange - Page 1 : comparemela.com

Transgene : Inside Information / Other news releases

P R E S S R E L E A S E Transgene - First Patient Dosed in Phase I Trial Evaluating TG6050, a Novel IL-12-Armed Oncolytic Virus Administered. | May 10, 2023

United statesMaud brandelyTransgene euronextSylvie berrebiLucie larguierCorporate communicationsAmerican association for cancer researchPatient dosedPhasei trial evaluatingArmed oncolytic virus administered intravenouslyNon small cell lung cancerPhasei delivirEuronext parisChief medical officerAmerican associationCancer research

Transgene : Inside Information / Other news releases

PRESS RELEASE Transgene Announces New Leadership Structure to Accelerate the Development of its Innovative Immunotherapy Portfolio . | May 5, 2023

United statesUnited kingdomTransgene euronextAlessandro rivaBen brahimSylvie berrebiLucie larguierLife sciencesIchnos sciencesCell gene therapy at gilead sciencesUniversity of milanCompany board of directorsCorporate communicationsCompensation committeeAffairs at novartis pharmaceuticalsGlobal head of oncology development

Transgene : January 19, 2021 - Transgene and BioInvent receive approval from ANSM to proceed with Phase I/IIa trial of anti-CTLA4-armed oncolytic virus BT-001 in solid tumors

P R E S S R E L E A S E Transgene and BioInvent receive approval from ANSM to proceed with Phase I/IIa trial of. | January 19, 2021

France generalMaud brandelyInstitute bordeauxGustave roussy institute parisHealth productsEuronext parisFrench national agencyChief medical officerGustave roussy instituteTransgene stock exchangePress releasePhase tng fr0005175080பிரான்ஸ் ஜநரல்நிறுவனம் போர்டியாக்ஸ்ஆரோக்கியம் ப்ராடக்ட்ஸ்தலைமை மருத்துவ அதிகாரி

vimarsana © 2020. All Rights Reserved.